Consensus Humana Inc. Deutsche Boerse AG

Stocks

HUM

US4448591028

Managed Healthcare

Market Closed - Deutsche Boerse AG 15:55:02 2026-09-18 EDT			5-day change	1st Jan Change
334.00 ^EUR	+0.60%		-4.57%	+53.14%

09-17	CVS Health's Aetna to streamline cancer treatment approvals	RE
09-11	BofA Adjusts Price Target on Humana to $510 From $500	MT

20706b37d.qC0_djYJc4cagyvRXbPl8bmXXVrou1taycFNwOci7BY.xHVcIk9_JeRVxxibBfGtpvPNGBG40gs7q_kYhp8TlGDKYno6Zz4jsXvkYg~1488190a94daf71050e87967b20a6f52

Analysts' recommendations: Humana Inc.

09-11	BofA Adjusts Price Target on Humana to $510 From $500	MT
08-05	Morgan Stanley Upgrades Humana to Equalweight From Underweight, Adjusts PT to $370 From $249	MT
07-31	TD Cowen Adjusts Humana Price Target to $370 From $350, Maintains Hold Rating	MT
07-31	Jefferies & Co Adjusts Humana Price Target to $420 From $290, Maintains Buy Rating	MT
07-31	Analyst recommendations: Apple, Baxter International, Dexcom, Flex, Humana, Stellantis…
07-30	Barclays Adjusts Price Target on Humana to $407 From $344, Maintains Equalweight Rating	MT
07-30	Guggenheim Adjusts Price Target on Humana to $471 From $269, Maintains Buy Rating	MT
07-30	Baird Adjusts Price Target on Humana to $390 From $205, Maintains Neutral Rating	MT
07-30	Oppenheimer Adjusts Price Target on Humana to $405 From $340, Maintains Outperform Rating	MT
07-30	Goldman Sachs Adjusts Price Target on Humana to $280 From $195, Maintains Sell Rating	MT
07-30	UBS Adjusts Price Target on Humana to $405 From $320, Maintains Neutral Rating	MT
07-30	Leerink Partners Upgrades Humana to Outperform From Market Perform, Adjusts PT to $513 From $255	MT
07-30	Evercore ISI Upgrades Humana to Outperform From In Line, Adjusts PT to $480 From $430	MT
07-30	Deutsche Bank Adjusts Humana PT to $436 From $441, Maintains Buy Rating	MT
07-30	Raymond James Downgrades Humana to Market Perform From Outperform	MT
07-30	Analysts recommendations: Humana, Lam Research, Procter & Gamble, Carvana, Fair Isaac…
07-29	Evercore ISI Upgrades Humana to Outperform From In Line, $480 Price Target	MT
07-29	BofA Securities Upgrades Humana to Buy From Neutral, Raises Price Target to $500 From $410	MT
07-14	Raymond James Adjusts Price Target on Humana to $425 From $260, Maintains Outperform Rating	MT
07-14	Truist Raises Price Target on Humana to $415 From $320, Keeps Hold Rating	MT
07-14	TD Cowen Adjusts Price Target on Humana to $350 From $211, Maintains Hold Rating	MT
07-14	Analyst recommendations: Apple, Halliburton, Qiagen, Skyworks, Delta Air Lines…
07-13	Humana Shares Rise After Upgrade From Wells Fargo	MT
07-13	Mizuho Adjusts Price Target on Humana to $468 From $390, Maintains Outperform Rating	MT
07-13	Wells Fargo Upgrades Humana to Overweight From Equalweight, Adjusts PT to $502 From $227	MT

More recommendations

Other Managed Healthcare

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	UNITEDHEALTH GROUP INC.					+27.81%
	ELEVANCE HEALTH, INC.					+9.84%
	CIGNA					+23.28%
	HUMANA INC.					+8.5%
	CENTENE CORPORATION					+10.24%
	MOLINA HEALTHCARE, INC.					+4.15%
	CLOVER HEALTH INVESTMENTS, CORP.					+20.52%
	PROGYNY, INC.					+26.86%
	ALIGNMENT HEALTHCARE, INC.					+166.24%
	Average					+33.05%
	Weighted average by Cap.					+22.07%